These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19089979)

  • 1. Intrinsic structural disorder of mouse proNGF.
    Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
    Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional properties of mouse proNGF.
    Paoletti F; Konarev PV; Covaceuszach S; Schwarz E; Cattaneo A; Lamba D; Svergun DI
    Biochem Soc Trans; 2006 Aug; 34(Pt 4):605-6. PubMed ID: 16856872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
    Fahnestock M; Yu G; Michalski B; Mathew S; Colquhoun A; Ross GM; Coughlin MD
    J Neurochem; 2004 May; 89(3):581-92. PubMed ID: 15086515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural biology. The p75 NGF receptor exposed.
    Zampieri N; Chao MV
    Science; 2004 May; 304(5672):833-4. PubMed ID: 15131296
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular and structural insight into proNGF engagement of p75NTR and sortilin.
    Feng D; Kim T; Ozkan E; Light M; Torkin R; Teng KK; Hempstead BL; Garcia KC
    J Mol Biol; 2010 Mar; 396(4):967-84. PubMed ID: 20036257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ProNGF inhibits NGF-mediated TrkA activation in PC12 cells.
    Sobottka B; Reinhardt D; Brockhaus M; Jacobsen H; Metzger F
    J Neurochem; 2008 Dec; 107(5):1294-303. PubMed ID: 18796003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75.
    He XL; Garcia KC
    Science; 2004 May; 304(5672):870-5. PubMed ID: 15131306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProNGF: a neurotrophic or an apoptotic molecule?
    Fahnestock M; Yu G; Coughlin MD
    Prog Brain Res; 2004; 146():101-10. PubMed ID: 14699959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sortilin is essential for proNGF-induced neuronal cell death.
    Nykjaer A; Lee R; Teng KK; Jansen P; Madsen P; Nielsen MS; Jacobsen C; Kliemannel M; Schwarz E; Willnow TE; Hempstead BL; Petersen CM
    Nature; 2004 Feb; 427(6977):843-8. PubMed ID: 14985763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct intracellular selection and biochemical characterization of a recombinant anti-proNGF single chain antibody fragment.
    Paoletti F; Malerba F; Konarev PV; Visintin M; Scardigli R; Fasulo L; Lamba D; Svergun DI; Cattaneo A
    Arch Biochem Biophys; 2012 Jun; 522(1):26-36. PubMed ID: 22516657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin.
    Clewes O; Fahey MS; Tyler SJ; Watson JJ; Seok H; Catania C; Cho K; Dawbarn D; Allen SJ
    J Neurochem; 2008 Nov; 107(4):1124-35. PubMed ID: 18808449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
    Wehrman T; He X; Raab B; Dukipatti A; Blau H; Garcia KC
    Neuron; 2007 Jan; 53(1):25-38. PubMed ID: 17196528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.
    Barcelona PF; Saragovi HU
    Mol Cell Biol; 2015 Oct; 35(19):3396-408. PubMed ID: 26217017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor and its precursor differentially regulate hair cycle progression in mice.
    Peters EM; Hendrix S; Gölz G; Klapp BF; Arck PC; Paus R
    J Histochem Cytochem; 2006 Mar; 54(3):275-88. PubMed ID: 16009967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pro-peptide of proNGF: structure formation and intramolecular association with NGF.
    Kliemannel M; Golbik R; Rudolph R; Schwarz E; Lilie H
    Protein Sci; 2007 Mar; 16(3):411-9. PubMed ID: 17242381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF.
    Larsson E; Kuma R; Norberg A; Minde J; Holmberg M
    Neurobiol Dis; 2009 Feb; 33(2):221-8. PubMed ID: 19038341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
    Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
    J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor beta/pro-nerve growth factor and their receptors in normal human oral mucosa.
    Hayashi K; Storesund T; Schreurs O; Khuu C; Husvik C; Karatsaidis A; Helgeland K; Martin-Zanca D; Schenck K
    Eur J Oral Sci; 2007 Oct; 115(5):344-54. PubMed ID: 17850422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.